Analysis of cell surface N-glycosylation of the Human embryonic kidney 293T cell line

Journal of Carbohydrate Chemistry

Volumn 30, Issue 4-6, 2011, Pages 218-232

  Reinke, Stefan O ^a   Bayer, Marion ^a   Berger, Markus ^b   Blanchard, Véronique ^b   Hinderlich, Stephan ^a  

^a Institut für Soziale Gesundheit Katholische Hochschule für Sozialwesen Berlin   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Glycosyltransferases; HEK293T; Maldi tof ms; N glycosylation; RT PCR

Indexed keywords

EID: 84855795023     PISSN: 07328303     EISSN: 15322327     Source Type: Journal    
DOI: 10.1080/07328303.2011.600489     Document Type: Article

References (21)

1. Sinclair, A. M.; Elliott, S. Glycoengineering: the effect of glycosylation on the properties of therapeutic proteins. J. Pharm. Sci. 2005, 94, 1626-1635. (Pubitemid 41360859)
2. Cumming, D. A. Glycosylation of recombinant protein therapeutics: control and functional implications. Glycobiology 1991, 1, 115-130.
3. Aebi, M.; Hennet, T. Congenital disorders of glycosylation: genetic model systems lead the way. Trends Cell. Biol. 2001, 11, 136-141. (Pubitemid 32289444)
4. Scanlin, T. F.; Glick, M. C. Terminal glycosylation and disease: influence on cancer and cystic fibrosis. Glycoconj. J. 2000, 17, 617-626. (Pubitemid 32480348)
5. Arnold, J. N.; Saldova, R.; Hamid, U. M.; Rudd, P. M. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics 2008, 8, 3284-3293.
6. Su, D.; Zhao, H.; Xia, H. Glycosylation-modified erythropoietin with improved halflife and biological activity. Int. J. Hematol. 2010, 91, 238-244.
7. Weiss, P.; Ashwell, G. The asialoglycoprotein receptor: properties and modulation by ligand. Prog. Clin. Biol. Res. 1989, 300, 169-184.
8. Shields, R. L.; Lai, J.; Keck, R.; O'Connell, L. Y.; Hong, K.; Meng, Y. G.; Weikert, S. H.; Presta, L. G. Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcgammaRIII and antibody-dependent cellular toxicity. J. Biol. Chem. 2002, 277, 26733-26740. (Pubitemid 34951677)
9. Niwa, R.; Shoji-Hosaka, E.; Sakurada, M.; Shinkawa, T.; Uchida, K.; Nakamura, K.; Matsushima, K.; Ueda, R.; Hanai, N.; Shitara, K. Defucosylated anti-CC chemokine receptor 4 IgG1 with enhanced antibody-dependent cellular cytotoxicity shows potent therapeutic activity to T cell leukemia and lymphoma. Cancer Res. 2004, 64, 2127-2133. (Pubitemid 38339463)
10. Stanley, P., Schachter, H., Taniguchi, N. N-Glycans. In Essentials of Glycobiology. 2nd edition; Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., Etzler, M. E., Eds.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2009; Chapter 8.
11. Takahashi, M.; Kuroki, Y.; Ohtsubo, K.; Taniguchi, N. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr. Res. 2009, 344, 1387-1390.
12. Harduin-Lepers, A.; Vallejo-Ruiz, V.; Krzewinski-Recchi, M. A.; Samyn-Petit, B.; Julien, S.; Delannoy, P. The human sialyltransferase family. Biochimie 2001, 83, 727-737. (Pubitemid 32821237)
13. Lieke, T.; Gröbe, D.; Blanchard, V.; Grunow, D.; Tauber, R.; Zimmermann-Kordmann, M.; Jacobs, T.; Reutter, W. Invasion of Trypanosoma cruzi into host cells is impaired by N-propionylmannosamine and other N-acylmannosamines. Glycoconj. J. 2011, 28, 31-37.
14. Wada, Y.; Azadi, P.; Costello, C. E.; Dell, A.; Dwek, R. A.; Geyer, H.; Geyer, R.; Kakehi, K.; Karlsson, N. G.; Kato, K.; Kawasaki, N.; Khoo, K. H.; Kim, S.; Kondo, A.; Lattova, E.; Mechref, Y.; Miyoshi, E.; Nakamura, K.; Narimatsu, H.; Novotny, M. V.; Packer, N. H.; Perreault, H.; Peter-Katalinic, J.; Pohlentz, G.; Reinhold, V. N.; Rudd, P. M.; Suzuki, A.; Taniguchi, N. Comparison of the methods for profiling glycoprotein glycans-HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology 2007, 17, 411-422. (Pubitemid 46432012)
15. Maass, K.; Ranzinger, R.; Geyer, H.; von der Lieth, C. W.; Geyer, R. "Glycopeakfinder"-de novo composition analysis of glycoconjugates. Proteomics 2007, 7, 4435-4444.
16. Ceroni, A.; Maass, K.; Geyer, H.; Geyer, R.; Dell, A.; Haslam, S. M. GlycoWorkbench: A Tool for the computer-assisted annotation of mass spectra of glycans. J. Pro-teome Res. 2008, 7, 1650-1659.
17. Stanley, P., Cummings, R. D. Structures common to different glycans. In Essentials of Glycobiology. 2nd edition; Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., Etzler, M. E., Eds.; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 2009; Chapter 13.
18. Park, E. I.; Mi, Y.; Unverzagt, C.; Gabius, H. J.; Baenziger, J. U. The asialoglycoprotein receptor clears glycoconjugates terminating with sialic acid alpha 2, 6GalNAc. Proc. Natl. Acad. Sci. USA 2005, 102, 17125-17129. (Pubitemid 41692694)
19. Chitlaru, T.; Kronman, C.; Zeevi, M.; Kam, M.; Harel, A.; Ordentlich, A.; Velan, B.; Shafferman, A. Modulation of circulatory residence of recombinant acetylcholinesterase through biochemical or genetic manipulation of sialylation levels. Biochem. J. 1998, 336, 647-658. (Pubitemid 29008024)
20. North, S. J.; Huang, H. H.; Sundaram, S.; Jang-Lee, J.; Etienne, A. T.; Trollope, A.; Chalabi, S.; Dell, A.; Stanley, P.; Haslam, S. M. Glycomics profiling of Chinese hamster ovary cell glycosylation mutants reveals N-glycans of a novel size and complexity. J. Biol. Chem. 2010, 285, 5759-5775.
21. Heiskanen, A.; Hirvonen, T.; Salo, H.; Impola, U.; Olonen, A.; Laitinen, A.; Tiitinen, S.; Natunen, S.; Aitio, O.; Miller-Podraza, H.; Wuhrer, M.; Deelder, A. M.; Natunen, J.; Laine, J.; Lehenkari, P.; Saarinen, J.; Satomaa, T.; Valmu, L. Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj. J. 2009, 26, 367-384.